326
Views
1
CrossRef citations to date
0
Altmetric
Review Article

Regulatory context and validation of assays for clinical mass spectrometry proteomics (cMSP) methods

, , , , , , & show all
Pages 346-358 | Received 17 Jan 2018, Accepted 25 Apr 2018, Published online: 23 May 2018

References

  • Grebe SK, Singh RJ. LC–MS/MS in the clinical laboratory – where to from here? Clin Biochem Rev. 2011;32:5–31.
  • Delaby C, Bros P, Vialaret J, et al. Quantification of hepcidin-25 in human cerebrospinal fluid using LC–MS/MS. Bioanalysis. 2017;9:337–347.
  • Hawkridge AM, Heublein DM, Bergen HR, et al. Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure. Proc Natl Acad Sci USA. 2005;102:17442–17447.
  • Agger SA, Marney LC, Hoofnagle AN. Simultaneous quantification of apolipoprotein A-I and apolipoprotein B by liquid-chromatography-multiple-reaction-monitoring mass spectrometry. Clin Chem. 2010;56:1804–1813.
  • Wildsmith KR, Han B, Bateman RJ. Method for the simultaneous quantitation of apolipoprotein E isoforms using tandem mass spectrometry. Anal Biochem. 2009;395:116–118.
  • Hirtz C, Vialaret J, Gabelle A, et al. From radioimmunoassay to mass spectrometry: a new method to quantify orexin-A (hypocretin-1) in cerebrospinal fluid. Sci Rep. 2016;6:25162.
  • Fortin T, Salvador A, Charrier JP, et al. Clinical quantitation of prostate-specific antigen biomarker in the low nanogram/milliliter range by conventional bore liquid chromatography–tandem mass spectrometry (multiple reaction monitoring) coupling and correlation with ELISA tests. Mol Cell Proteomics. 2009;8:1006–1015.
  • Aebersold R, Mann M. Mass spectrometry-based proteomics [Research support, non-US Gov't Research Support, US Gov't, P.H.S. Review]. Nature. 2003;422:198–207.
  • Gagliardi J. The global harmonization task force: what you need to know. Biomed Instrum Technol. 2009;43:403–405.
  • (IMDRF) TIMDRF. The International Medical Device Regulators Forum (IMDRF). Available from: http://www.imdrf.org/
  • Congress U. Medicare, Medicaid and CLIA programs; revision of the laboratory regulations for the Medicare, Medicaid, and Clinical Laboratories Improvement Act of 1967 programs–HCFA. Final rule with comment period. Fed Regist. 1990;55:9538–9610.
  • Dati F. The new European directive on in vitro diagnostics [Review]. Clin Chem Lab Med. 2003;41:1289–1298.
  • Grifa RA, Pozzoli G. Performance evaluation of in vitro diagnostic medical devices: methodology and differences compared to studies on other medical devices. Microchem J. 2018;136:279–282.
  • Council EPa. In vitro diagnostic medical devices. 1988. Available from: https://ec.europa.eu/growth/single-market/european-standards/harmonised-standards/iv-diagnostic-medical-devices_fr
  • Council EPa. The new regulations on medical devices. Available from: https://ec.europa.eu/growth/sectors/medical-devices/regulatory-framework_en
  • Standardization IOf. ISO 13485 – medical devices. 2016. Available from: https://www.iso.org/iso-13485-medical-devices.html
  • Standardization IOf. ISO 15189:2012 Medical laboratories – requirements for quality and competence. 2012. Available from: https://www.iso.org/standard/56115.html
  • Álvarez SI, Andreu FAB. Procedures for Validation of Diagnostic Methods in Clinical Laboratory Accredited by ISO 15189. In: Eldin AB, editor. Modern approaches to quality control. INTECH Open Access Publisher; 2011.
  • Berwouts S, Morris MA, Dequeker E. Approaches to quality management and accreditation in a genetic testing laboratory. Eur J Hum Genet. 2010;18:S1–S19.
  • Magnusson B, Örnemark U. Eurachem guide: the fitness for purpose of analytical methods—a laboratory guide to method validation and related topics. 2014. NCBI PUBCHEM Disponível em. Available from: https://pubchem ncbi nlm nih gov/compound/688387# section=Top
  • Vitzthum F, Siest G, Bunk DM, et al. Metrological sharp shooting for plasma proteins and peptides: the need for reference materials for accurate measurements in clinical proteomics and in vitro diagnostics to generate reliable results. Prot Clin Appl. 2007;1:1016–1035.
  • Standardization IOf. ISO 1087-1:2000 Terminology work – vocabulary – part 1: theory and application. 2000. Available from: https://www.iso.org/standard/20057.html
  • Ferard G, Pontet F, Giroud C, et al. [Introducing the new international vocabulary of metrology]. Ann Biol Clin (Paris). 2009;67:591–594.
  • Vesper H, Emons H, Gnezda M, et al. Characterization and qualification of commutable reference materials for laboratory medicine; approved guidelines. Clin Lab Stand Inst. 2010;30.
  • Maclean B, Tomazela DM, Abbatiello SE, et al. Effect of collision energy optimization on the measurement of peptides by selected reaction monitoring (SRM) mass spectrometry. Anal Chem. 2010;82:10116–10124.
  • Mallick P, Schirle M, Chen SS, et al. Computational prediction of proteotypic peptides for quantitative proteomics [Research Support, N.I.H., Extramural]. Nat Biotechnol. 2007;25:125–131.
  • Kuster B, Schirle M, Mallick P, et al. Scoring proteomes with proteotypic peptide probes [Review]. Nat Rev Mol Cell Biol. 2005;6:577–583.
  • Adam BW, Alexander JR, Smith SJ, et al. Recoveries of phenylalanine from two sets of dried-blood-spot reference materials: prediction from hematocrit, spot volume, and paper matrix. Clin Chem. 2000;46:126–128.
  • Deutsch EW, Albar JP, Binz PA, et al. Development of data representation standards by the human proteome organization proteomics standards initiative [Research Support, American Recovery and Reinvestment Act]. J Am Med Inform Assoc. 2015;22:495–506.
  • Ricos C, Alvarez V, Cava F, et al. Current databases on biological variation: pros, cons and progress. Scand J Clin Lab Invest. 1999;59:491–500.
  • Aarsand AK, Roraas T, Sandberg S. Biological variation – reliable data is essential [Comment Editorial]. Clin Chem Lab Med. 2015;53:153–154.
  • Myers GL, Miller WG, Coresh J, et al. Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program [Review]. Clin Chem. 2006;52:5–18.
  • Magnussen CG, Venn A, Thomson R, et al. The association of pediatric low- and high-density lipoprotein cholesterol dyslipidemia classifications and change in dyslipidemia status with carotid intima-media thickness in adulthood evidence from the cardiovascular risk in Young Finns study, the Bogalusa Heart study, and the CDAH (Childhood Determinants of Adult Health) study. J Am Coll Cardiol. 2009;53:860–869.
  • Medicine JCfTiL. Joint committee for traceability in laboratory medicine. Available from: https://www.bipm.org/en/committees/jc/jctlm/
  • Josephs RD, Stoppacher N, Westwoo S, et al. Concept paper on SI value assignment of purity – model for the classification of peptide/protein purity determinations. J Chem Metrol. 2017;11:1–8.
  • Narayanam M, Handa T, Sharma P, et al. Critical practical aspects in the application of liquid chromatography–mass spectrometric studies for the characterization of impurities and degradation products [Review]. J Pharm Biomed Anal. 2014;87:191–217.
  • Huang T, Zhang W, Dai X, et al. Precise measurement for the purity of amino acid and peptide using quantitative nuclear magnetic resonance [Research Support, Non-US Gov't]. Talanta. 2014;125:94–101.
  • Addona TA, Abbatiello SE, Schilling B, et al. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat Biotechnol. 2009;27:633–641.
  • Hoofnagle AN. Quantitative clinical proteomics by liquid chromatography–tandem mass spectrometry: assessing the platform. Clin Chem. 2010;56:161–164.
  • Kuhn E, Whiteaker JR, Mani DR, et al. Interlaboratory evaluation of automated, multiplexed peptide immunoaffinity enrichment coupled to multiple reaction monitoring mass spectrometry for quantifying proteins in plasma. Mol Cell Proteomics. 2012;11:M111 013854.
  • Proc JL, Kuzyk MA, Hardie DB, et al. A quantitative study of the effects of chaotropic agents, surfactants, and solvents on the digestion efficiency of human plasma proteins by trypsin [Research Support, N.I.H., Extramural Research Support, Non-US Gov't]. J Proteome Res. 2010;9:5422–5437.
  • Cheung CS, Anderson KW, Wang M, et al. Natural flanking sequences for peptides included in a quantification concatamer internal standard. Anal Chem. 2015;87:1097–1102.
  • Cox HD, Lopes F, Woldemariam GA, et al. Interlaboratory agreement of insulin-like growth factor 1 concentrations measured by mass spectrometry. Clin Chem. 2014;60:541–548.
  • Yi J, Liu Z, Craft D, et al. Intrinsic peptidase activity causes a sequential multi-step reaction (SMSR) in digestion of human plasma peptides. J Proteome Res. 2008;7:5112–5118.
  • Bystrom CE, Salameh W, Reitz R, et al. Plasma renin activity by LC–MS/MS: development of a prototypical clinical assay reveals a subpopulation of human plasma samples with substantial peptidase activity [Comparative Study]. Clin Chem. 2010;56:1561–1569.
  • Grant RP, Hoofnagle AN. From lost in translation to paradise found: enabling protein biomarker method transfer by mass spectrometry. Clin Chem. 2014;60:941–944.
  • Armbruster DA, Pry T. Limit of blank, limit of detection and limit of quantitation. Clin Biochem Rev. 2008;29: S49–S52.
  • Jenkins R, Duggan JX, Aubry AF, et al. Recommendations for validation of LC–MS/MS bioanalytical methods for protein biotherapeutics. AAPS J. 2015;17:1–16.
  • Mitulovic G, Stingl C, Steinmacher I, et al. Preventing carryover of peptides and proteins in nano LC–MS separations [Research Support, Non-US Gov't]. Anal Chem. 2009;81:5955–5960.
  • Westgard JO. Managing quality vs. measuring uncertainty in the medical laboratory. Clin Chem Lab Med. 2010;48:31–40.
  • Giroud C, Arnaud J, Vassault A. Guide for evaluating the uncertainties of measures of medical biology analysis. Ann Biol Clin. 2010;68:237–246.
  • Boyd JC. Defining laboratory reference values and decision limits: populations, intervals, and interpretations [Review]. Asian J Androl. 2010;12:83–90.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.